Multiple studies have shown that oxidative modifi cations of LDL (oxLDL) are a major factor in the development of atherosclerosis ( 1-6 ). The level of oxLDL increases dramatically with hypercholesterolemia in animal models of atherosclerosis ( 7,8 ), and in humans ( 9, 10 ), it is found in atherosclerotic lesions ( 11 ). It is also well established that dyslipidemia-induced dysfunction of vascular endothelial cells is a critical step in the early stage of atherosclerosis (e.g., Refs. 12-14 ) and a strong predictor of cardiovascular disease (CVD) development ( 15-17 ). The mechanisms, however, of dyslipidemia-induced endothelial dysfunction are still poorly understood. Our recent studies have shown that exposure to oxLDL in vitro or to plasma dyslipidemia in vivo signifi cantly increases the stiffness of aortic endothelial cells, which in turn is associated with an increase in endothelial contractility, enhanced angiogenic potential, and sensitivity to shear stress (18)(19)(20). Furthermore, unexpectedly, our studies showed that dyslipidemia-induced endothelial stiffening is caused not by cholesterol loading but by disruption of lipid packing of cholesterol-rich membrane domains in endothelial cells ( 18,19,21 ). Consistent with these observations, oxLDLinduced endothelial stiffness could be fully reversed by enriching the cells with cholesterol, even though oxLDL had no effect on the cholesterol content of endothelial membranes ( 19 ). These studies led us to the hypothesis that oxLDL induces endothelial dysfunction by inserting oxysterols into the plasma membrane, resulting in the disruption of cholesterol-rich membrane domains and endothelial stiffening. The goal of this study, therefore, was to determine the impact of oxysterols on endothelial stiffness.Abstract Endothelial dysfunction is a key step in atherosclerosis development. Our recent studies suggested that oxLDL-induced increase in endothelial stiffness plays a major role in dyslipidemia-induced endothelial dysfunction. In this study, we identify oxysterols, as the major component of oxLDL, responsible for the increase in endothelial stiffness. Using Atomic Force Microscopy to measure endothelial elastic modulus, we show that endothelial stiffness increases with progressive oxidation of LDL and that the two lipid fractions that contribute to endothelial stiffening are oxysterols and oxidized phosphatidylcholines, with oxysterols having the dominant effect. Furthermore, endothelial elastic modulus increases as a linear function of oxysterol content of oxLDL. Specifi c oxysterols, however, have differential effects on endothelial stiffness with 7-ketocholesterol and 7 ␣ -hydroxycholesterol, the two major oxysterols in oxLDL, having the strongest effects. 27-hydroxycholesterol, found in atherosclerotic lesions, also induces endothelial stiffening. For all oxysterols, endothelial stiffening is reversible by enriching the cells with cholesterol. ox-LDL-induced stiffening is accompanied by incorporation of oxysterols into endothelial cells. We fi nd signif...